Immunotherapy and warts: a point of view
Authors:
- Mauricio Goihman-YahrMGMauricio Goihman-Yahr
- Orin M. GoldblumOGOrin M. Goldblum
- 30 April 2008
- journal article
- Published by Elsevier in Clinics in Dermatology
- Vol. 26 (2) , 223-225
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Randomized Controlled Trial of an Adjuvanted Human Papillomavirus (HPV) Type 6 L2E7 Vaccine: Infection of External Anogenital Warts with Multiple HPV Types and Failure of Therapeutic VaccinationThe Journal of Infectious Diseases, 2005
- Human Papillomavirus Gene Expression in Cutaneous Squamous Cell Carcinomas from Immunosuppressed and Immunocompetent IndividualsJournal of Investigative Dermatology, 2005
- Cutting Edge: Priming of CTL by Transcutaneous Peptide Immunization with ImiquimodThe Journal of Immunology, 2005
- Mechanism of Action and Emerging Role of Immune Response Modifier Therapy in Dermatologic ConditionsJournal of Cutaneous Medicine and Surgery, 2004
- High Prevalence of Cutaneous Human Papillomavirus DNA on the Top of Skin Tumors but not in “Stripped” Biopsies from the Same TumorsJournal of Investigative Dermatology, 2004
- Use of intralesional interferon-α for the treatment of recalcitrant oral warts in patients with AIDS: A report of 4 casesOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2001
- Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%Antiviral Research, 1999
- Human leukocyte derived interferon-alpha in a hydrophilic gel for the treatment of intravaginal warts in women: a placebo-controlled, double-blind studyInternational Journal of STD & AIDS, 1998
- The rabbit viral skin papillomas and carcinomas: A model for the immunogenetics of HPV-associated carcinogenesisClinics in Dermatology, 1997
- UNILATERAL DINITROCHLOROBENZENE IMMUNOPATHY OF RECALCITRANT WARTSThe Lancet, 1978